Cell lines and methods for screening growth regulatory compounds
This invention provides a novel murine cultured cell line which is derived from primary mouse embryo fibroblasts and which exhibits inducer-regulated growth kinetics. The cell line has the potential to grow either linearly or exponentially depending on exposure to an appropriate inducing agent. A corresponding cell line that does not respond to the inducing agent is also provided. The paired cell line system provides a valuable research tool for the development of therapeutic agents that target cells exhibiting deregulated growth kinetics, and also enables the identification of potential carcinogenic agents that alter stem cell renewal kinetics.
Latest Fox Chase Cancer Center Patents:
- GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES
- GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES
- HUMAN CHORIONIC GONADOTROPIN VARIANT PEPTIDES AND TREATMENT OF BREAST CANCER
- HUMAN CHORIONIC GONADOTROPIN VARIANT PEPTIDES AND TREATMENT OF BREAST CANCER
- EGFR/NEDD9/TGF-? interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders
Claims
1. A murine cell line devoid of functional endogenous genes encoding p53, the cell line being stably transformed with an exogenous DNA molecule comprising a p53 coding sequence operably linked to an inducible promoter that activates expression of the p53 coding sequence upon exposure to an inducing agent, the cell line exhibiting exponential growth kinetics in the absence of the inducing agent and renewal growth kinetics upon exposure to the inducing agent.
2. The cell line of claim 1, which is a murine embryo fibroblast cell line.
3. The cell line of claim 2, derived from a murine fibroblast 10(1) cell line.
4. The cell line of claim 1, wherein the p53 coding sequence is a mouse coding sequence.
5. The cell line of claim 1, wherein the inducible promoter comprises at least one metal response element.
6. The cell line of claim 5, wherein the inducing agent is zinc.
7. A test kit for determining the effect of a substance on cell growth kinetics, the kit comprising and aliquot of the cell line of claim 1, and directions for using the cell line.
8. The test kit of claim 7, which further comprises an aliquot of the inducing agent.
9. A murine 10(1) cell line, stably transfected with an exogenous DNA molecule comprising a p53 coding sequence operably linked to a metal response element-containing promoter that activates expression of the p53 coding sequence upon exposure to a metal response element inducing agent, the cell line exhibiting exponential growth kinetics in the absence of the inducing agent and renewal growth kinetics upon exposure to the inducing agent.
10. The cell line of claim 9, stably transformed by co-transfection with plasmids pHMT.wt and pJ4.OMEGA..puro.
11. The cell line of claim 10, selected from the group consisting of Ind-4 and Ind-8.
12. A paired cell line system for determining the effect of a substance on cell growth kinetics, the system comprising an inducible cell line and a control cell line, both the lines derived from a mammalian parent cell line devoid of functional endogenous genes encoding p53;
- a) the inducible cell line being stably transfected with an exogenous DNA molecule comprising a p53 coding sequence operably linked to an inducible promoter that activates expression of the p53 coding sequence upon exposure to an inducing agent, the inducible cell line exhibiting exponential growth kinetics in the absence of the inducing agent and renewal growth kinetics upon exposure to the inducing agent;
- b) the control cell line being stably transfected with an exogenous DNA molecule comprising the inducible promoter but lacking the p53 coding sequence, the control cell line exhibiting exponential growth kinetics in the presence or absence of the inducing agent.
13. The system of claim 11, wherein the parental cell line is a murine cell line.
14. The system of claim 13, wherein the parental cell line is a murine embryo fibroblast cell line.
15. The system of claim 14, wherein the parental cell line is derived from a murine fibroblast 10(1) cell line.
16. The system of claim 12, wherein the p53 coding sequence is a mouse coding sequence.
17. The system of claim 12, wherein the inducible promoter comprises at least one metal response element.
18. The system of claim 17, wherein the inducing agent is zinc.
19. A test kit for determining the effect of a substance on cell growth kinetics, the kit comprising:
- a) an aliquot each of the inducible cell line and the control cell line of claim 12; and
- b) directions for using the cell lines.
20. The test kit of claim 19, which further comprises an aliquot of the inducing agent.
21. A paired cell line system for determining the effect of a substance on cell growth kinetics, the system comprising an inducible cell line and a control cell line, both lines derived from a murine 10(1) cell line, the inducible cell line being stably transfected with an exogenous DNA molecule comprising a p53 coding sequence operably linked to a metal response element-containing promoter that activates expression of the p53 coding sequence upon exposure to a metal response element inducing agent, the control cell line being stably transfected an exogenous DNA molecule comprising the metal response element-containing promoter but lacking the p53 coding sequence.
22. The system of claim 21, wherein the inducible cell line is stably transformed by co-transfection with plasmids pHMT.wt and pJ4.OMEGA..puro, and the control cell line is stably transfected by co-transfection with plasmids pM2.6 and pJ4.OMEGA..puro.
23. The system of claim 22, wherein the inducible cell line is selected from the group consisting of Ind-4 and Ind-8, and the control cell line is selected from the group consisting of Con-2 and Con-3.
24. A method for determining the effect of a substance on cell growth kinetics, the method comprising:
- a) providing an inducible cell line derived from a mammalian parent cell line devoid of functional endogenous genes encoding p53, the inducible cell line being stably transfected with an exogenous DNA molecule comprising a p53 coding sequence operably linked to an inducible promoter that activates expression of the p53 coding sequence upon exposure to an inducing agent, the inducible cell line exhibiting exponential growth kinetics in the absence of the inducing agent and renewal growth kinetics upon exposure to the inducing agent;
- b) exposing cells of the inducible cell line to the substance; and
- c) observing whether the exposure of the cells to the substance alters the growth kinetics of the cells, the alteration being indicative of the effect of the substance on cell growth kinetics.
25. The method of claim 24, wherein the cells are exposed to the substance in the absence of the inducing agent.
26. The method of claim 24, wherein the cells are exposed to the substance in the presence of the inducing agent.
27. The method of claim 24, which further comprises:
- d) providing a control cell line derived the mammalian parent cell line devoid of functional endogenous genes encoding p53, the control cell line being stably transfected with an exogenous DNA molecule comprising said inducible promoter but lacking said p53 coding sequence, the control cell line exhibiting exponential growth kinetics in the presence or absence of the inducing agent;
- b) exposing cells of the control cell line to the substance; and
- c) comparing the effect of the substance on the growth kinetics of the control cell line with the effect of the substance on the growth kinetics of the inducible cell line.
- Knudson, Seminars in Can. Biol., 3:99-106, 1992. Cairns, Nature, 255: 197-200 1975. Sherley, J., Biol Chem, 266: 24815-24828 1991. Sherley et al., Cell Proliferation 28: 137-144 1995. Sherley et al., PNAS USA, 92: 136-140 1995. Spalholz et al., Cell 42: 183-191 1985. Mc Neall et al., Gene, 76: 81-88 1989. Harvey & Levine, Genes & Development 5: 2375-2385 1991. Todaro & Green, J. Cell Biol., 17: 299-313 1963. Pereira--Smith & Smith, Somatic Cell Genet., 7:411-421 1981. Biscoff et al., Cancer Res., 50: 7979-7984 1990. Morganstern & Land, NVC. Acids Res. 18: 1068 1990. Yewdell, J. Virol., 59: 444-452 1986. Bohmer, Meth. in Cell Biol., 33: 173-184 1990. Shaw et al., PNAS, vol. 89, 1992, pp. 4495-4499. Harvey et al., Genes and Development, vol. 5, 1991, pp. 2375-2385.
Type: Grant
Filed: Dec 29, 1995
Date of Patent: Apr 21, 1998
Assignee: Fox Chase Cancer Center (Philadelphia, PA)
Inventors: James L. Sherley (Philadelphia, PA), Lee B. Riley (Landsdale, PA)
Primary Examiner: James Ketter
Law Firm: Dann, Dorfman, Herrell and Skillman
Application Number: 8/578,207
International Classification: C12Q 168;
